These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34089033)

  • 21. Nasal spray of an IgM-like ACE2 fusion protein HH-120 prevents SARS-CoV-2 infection: Two investigator-initiated postexposure prophylaxis trials.
    Song R; Chen X; Li B; Ni J; Zhou Y; Zhang H; Liang X; Zou L; Liu J; Yang F; Li G; Guo X; Liu Z; Mao F; Lei C; Sui J; Li W; Jin R
    J Med Virol; 2023 Dec; 95(12):e29275. PubMed ID: 38054556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.
    Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B
    Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
    Konrat R; Papp H; Kimpel J; Rössler A; Szijártó V; Nagy G; Madai M; Zeghbib S; Kuczmog A; Lanszki Z; Gesell T; Helyes Z; Kemenesi G; Jakab F; Nagy E
    Front Pharmacol; 2022; 13():861295. PubMed ID: 35846988
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series.
    Go CC; Pandav K; Sanchez-Gonzalez MA; Ferrer G
    Cureus; 2020 Nov; 12(11):e11315. PubMed ID: 33173650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection.
    Yang H; Chen Y; Jiang D; Feng X; Xu Y; Wei J; Zou Q; Yang Q; Chen J; Jiang X; Qin C; Huang Z; Wu C; Zhou Y; Li M; Yin L
    Antib Ther; 2023 Apr; 6(2):97-107. PubMed ID: 37077474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.
    Castellarnau A; Heery GP; Seta A; Luscombe CA; Kinghorn GR; Button P; McCloud P; Paull JRA
    Sci Rep; 2022 Jun; 12(1):10210. PubMed ID: 35715644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management.
    Chavda VP; Vora LK; Pandya AK; Patravale VB
    Drug Discov Today; 2021 Nov; 26(11):2619-2636. PubMed ID: 34332100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous cannabidiol β-cyclodextrin complexed polymeric micelle nasal spray to attenuate in vitro and ex vivo SARS-CoV-2-induced cytokine storms.
    Changsan N; Sawatdee S; Suedee R; Chunhachaichana C; Srichana T
    Int J Pharm; 2023 Jun; 640():123035. PubMed ID: 37182795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.
    Balmforth D; Swales JA; Silpa L; Dunton A; Davies KE; Davies SG; Kamath A; Gupta J; Gupta S; Masood MA; McKnight Á; Rees D; Russell AJ; Jaggi M; Uppal R
    J Clin Virol; 2022 Oct; 155():105248. PubMed ID: 35952426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding.
    Yip KM; Lee KM; Ng TB; Xu S; Yung KKL; Qu S; Cheung AKL; Sze SCW
    Chin Med; 2022 Jul; 17(1):88. PubMed ID: 35897044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children.
    Zhou J; Chen X; Lu Y; Wang L; Yu H
    J Clin Immunol; 2023 Jul; 43(5):862-864. PubMed ID: 36809596
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
    Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal sprays for treating COVID-19: a scientific note.
    Chavda VP; Baviskar KP; Vaghela DA; Raut SS; Bedse AP
    Pharmacol Rep; 2023 Apr; 75(2):249-265. PubMed ID: 36848033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.
    De Boeck I; Cauwenberghs E; Spacova I; Gehrmann T; Eilers T; Delanghe L; Wittouck S; Bron PA; Henkens T; Gamgami I; Simons A; Claes I; Mariën J; Ariën KK; Bakokimi D; Loens K; Jacobs K; Ieven M; Bruijning-Verhagen P; Delputte P; Coenen S; Verhoeven V; Lebeer S
    Microbiol Spectr; 2022 Oct; 10(5):e0168222. PubMed ID: 36154666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible Role of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Recovery of Post-COVID-19 Anosmia.
    Aref ZF; Bazeed SEES; Hassan MH; Hassan AS; Ghweil AA; Sayed MAA; Rashad A; Mansour H; Abdelmaksoud AA
    Infect Drug Resist; 2022; 15():5483-5494. PubMed ID: 36164334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the virus-laden standing water change the transmission intensity of SARS-CoV-2 after precipitation? A framework for empirical studies.
    He C; Wang X; Shui A; Zhou X; Liu S
    Environ Res; 2022 Dec; 215(Pt 1):114127. PubMed ID: 36041541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of exhaled SARS-CoV-2-laden aerosols in the interpersonal breathing microenvironment in a ventilated room with limited space air stability.
    Deng X; Gong G; He X; Shi X; Mo L
    J Environ Sci (China); 2021 Oct; 108():175-187. PubMed ID: 34465431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
    Bentley K; Stanton RJ
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Nasal Protection for Preventing SARS-CoV-2 Infection.
    Nocini R; Henry BM; Mattiuzzi C; Lippi G
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.